REAL WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD: INITIAL RESULTS FROM A LARGE TERTIARY CENTER

被引：0
|
作者：
Cohen, Nathaniel
Choden, Tenzin
Choi, David
Cleveland, Noa
Cohen, Russell
Dalal, Sushila
Sakuraba, Atsushi
Hanan, Ira
Rubin, David
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2022年 / 28卷
关键词：
D O I：
10.1093/ibd/izac015.175
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [11] Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center
    St-Pierre, Joelle
    Choi, David
    Fear, Evan
    Choi, Natalie K.
    Mathew, Alex J.
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Cleveland, Noa Krugliak
    Rubin, David T.
    DIGESTIVE DISEASES AND SCIENCES, 2025,
  • [12] Effectiveness and Safety of Risankizumab Induction Therapy in Crohn's Disease: Prospective Real-World Experience in a Large Tertiary Center
    Zinger, Adar
    Choi, David K.
    Choi, Natalie K.
    Garcia, Nicole M.
    Cohen, Russell D.
    Dalal, Sushila
    Cleveland, Noa Krugliak
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S834 - S834
  • [13] Effectiveness of Real-World Peanut Oral Immunotherapy at a Large Tertiary Referral Academic Center
    Wilson, Bridget
    Magier, Adam
    Andorf, Sandra
    Devonshire, Ashley
    Madis, Erick
    Rosenberg, Chen
    Durrani, Sandy
    Assa'ad, Amal
    Schwartz, Justin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB32 - AB32
  • [14] LONG-TERM SAFETY OF TOFACITINIB: REAL WORLD DATA FROM A TERTIARY CENTER
    Cohen, Nathaniel A.
    Steinberg, Joshua M.
    Silfen, Alexa
    Traboulsi, Cindy
    Singer, Jorie
    Patel, Shivani A.
    Cohen, Russell D.
    Dalal, Sushila
    Micic, Dejan
    Pekow, Joel R.
    Sakuraba, Atsushi
    Rubin, David T.
    GASTROENTEROLOGY, 2021, 160 (06) : S342 - S343
  • [15] Effectiveness and Safety of Ocrelizumab - Real-life Experience of a Tertiary Center
    Carvalho, Ines V.
    Cunha, Carolina
    Nunes, Carla
    Macario, Maria do Carmo
    Batista, Sonia
    Sousa, Livia Maria
    Correia, Ines
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1006 - 1007
  • [16] Safety and effectiveness of cladribine tablets for multiple sclerosis: Results from a single-center real-world cohort
    Aerts, Sofie
    Khan, Hamza
    Severijns, Deborah
    Popescu, Veronica
    Peeters, Liesbet M.
    Van Wijmeersch, Bart
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 75
  • [17] Real-world Effectiveness and Safety of Fingolimod in Relapse-Remitting Multiple Sclerosis in a Portuguese Tertiary Center
    Jorge, A. F.
    Ramos-Lopes, J.
    Correira, I.
    Batista, S.
    Nunes, C.
    Macario, M. C.
    Campelo, I.
    Sousa, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 922 - 922
  • [18] Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres
    Pfeuffer, Steffen
    Rolfes, Leoni
    Hackert, Jana
    Kleinschnitz, Konstanze
    Ruck, Tobias
    Wiendl, Heinz
    Klotz, Luisa
    Kleinschnitz, Christoph
    Meuth, Sven G.
    Pul, Refik
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (02) : 257 - 268
  • [19] Preliminary cladribine effectiveness and safety results: real world data
    Ubago Perez, R.
    Alvarez Sanchez, R.
    Nieto Gomez, P.
    Portillo Haro, S.
    Cabeza Barrera, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 284 - 285
  • [20] EFFECTIVENESS AND SAFETY OF PEMBROLIZUMAB IN ADVANCED OR METASTATIC MELANOMA: PRELIMINARY RESULTS FROM REAL WORLD
    Cardoso Borges, F.
    Murteira, R.
    Ramos, C.
    Soares, P.
    Ferreira, M.
    Furtado, C.
    Miranda, A.
    Alves da Costa, F.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
12345